Wiebking named new president of Provena; Acclaimed scientist preps first skin cancer vax trial;

> Provena Health just named Guy Wiebking its new president and CEO. Wiebking replaces Steven Hunter, who was the chairman of Provena's board of directors for five years. Hunter also served as vice president of Abbot Laboratories' hospital product division. Article

> Sen. Tom Daschle, former Majority Leader, has been nominated to run HHS (or so sources tell a variety of newspapers, including the Washington Post). Rep. Henry Waxman's will take over of the House Energy and Commerce Committee, which oversees the FDA and the drug and device industries, among many others. FiercePharma

> Australia's Ian Frazer has been using his knowledge of human papilloma virus to create an experimental jab to prevent skin cancer. And now he says he's ready to launch the first human trial of a new vaccine that has already proven effective in preventing skin cancer in animals. FierceVaccines

> According to the Washington Post, about 5 percent of people who show signs for serious illness are being tested routinely for AIDS, going against advice from doctors. Article

And Finally... Guess you could call it beginner's luck. Article

Suggested Articles

The profit margins and management of Community Health Group raise questions about oversight of managed care insurers.

Financial experts are warning practices about the pitfalls of promoting medical credit cards to their patients.

A proposed rule issued by HHS on Tuesday would expand short-term coverage, a move Seema Verma said will have "virtually no impact" on ACA premiums.